Registry for patients referred to cardio-oncology
Cardio-Oncologie: étude Pilote évaluant la faisabilité, Utilité Concrète, Interdisciplinaire d'Une Unité Spécialisée
This study is collecting information from cancer patients who are referred for heart health checks to see how cancer treatments might affect their hearts.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | European Georges Pompidou Hospital Academic / other |
| Locations | 1 site (Paris) |
| Trial ID | NCT04407780 on ClinicalTrials.gov |
What this trial studies
This observational registry aims to gather data on patients referred for cardio-oncology assessment, focusing on the intersection of cancer and heart health. By collecting prospective data, the study seeks to provide a clearer understanding of cardiotoxicity associated with cancer treatments and to identify early signals of heart-related issues in cancer patients. The registry will also support ancillary projects targeting specific cancer types and treatment regimens. The goal is to enhance the knowledge base in the emerging field of cardio-oncology.
Who should consider this trial
Good fit: Ideal candidates for this registry are patients who have been referred for cardio-oncology assessment due to their cancer treatment.
Not a fit: Patients who refuse to participate in the registry will not benefit from the data collection and insights generated.
Why it matters
Potential benefit: If successful, this registry could lead to improved monitoring and management of heart health in cancer patients, potentially reducing the risk of cardiotoxicity.
How similar studies have performed: While the field of cardio-oncology is emerging, similar registries have shown promise in enhancing understanding of the relationship between cancer treatments and cardiovascular health.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * referred to cardio-oncology Exclusion Criteria: * refusal to participate
Where this trial is running
Paris
- Assistance Publique Hôpitaux de Paris - Centre Université de Paris — Paris, France (Recruiting)
Study contacts
- Study coordinator: Mariana Mirabel, MD, PhD
- Email: mariana.mirabel@aphp.fr
- Phone: +33156095636
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.